Vivani Chief Executive Officer Adam Mendelsohn, Ph.D., stated, "Our ongoing first-in-human study, LIBERATE-1, remains on track to deliver key data in mid-2025 with the aim of validating our ...

Rick Blum is meticulous about planning, ordering, and taking the medication he is prescribed to slow the progression of ...

Q1 2025 Earnings Call Transcript May 12, 2025 Xtant Medical Holdings, Inc. beats earnings expectations. Reported EPS is ...